Oscar Health, Inc. (OSCR) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
Oscar Health, Inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $1,040,851,000.00Payables to CMS → Operating adjustments reconciliation: $3,365,194,000.00Benefits payable → Operating adjustments reconciliation: $443,050,000.00Change in provision for credit losses → Operating adjustments reconciliation: $48,072,000.00Stock-based compensation expense → Operating adjustments reconciliation: $36,623,000.00Accounts payable and other liabilities → Operating adjustments reconciliation: $20,408,000.00Depreciation and amortization expense → Operating adjustments reconciliation: $13,049,000.00Amortization of debt issuance costs → Operating adjustments reconciliation: $2,163,000.00Unearned premiums → Operating adjustments reconciliation: $1,302,000.00Operating adjustments reconciliation → Net cash from operating activities: $3,670,474,000.00Operating adjustments reconciliation → Reinsurance recoverable: $96,794,000.00Operating adjustments reconciliation → Accounts receivable: $65,448,000.00Operating adjustments reconciliation → Receivables from CMS: $44,721,000.00Operating adjustments reconciliation → Other assets: $26,660,000.00Operating adjustments reconciliation → Net accretion of investments: $15,285,000.00Operating adjustments reconciliation → Deferred taxes: $7,731,000.00Operating adjustments reconciliation → Net realized gain on sale of financial instruments: $1,732,000.00Operating adjustments reconciliation → Reinsurance payable: $1,016,000.00Proceeds from exercise of stock options and stock purchase agreement → financing reconciliation: $29,904,000.00financing reconciliation → Net cash from financing activities: $9,695,000.00financing reconciliation → Tax payments related to net settlement of share-based awards: $11,920,000.00financing reconciliation → Payments of debt issuance costs: $4,919,000.00financing reconciliation → Earn-out Liability Payout: $3,370,000.00Net cash used in investing activities → investing reconciliation: $3,424,865,000.00Sale of investments → investing reconciliation: $983,943,000.00Maturity and paydowns of investments → investing reconciliation: $553,943,000.00Change in restricted deposits → investing reconciliation: $606,000.00investing reconciliation → Purchase of investments: $4,942,801,000.00investing reconciliation → Purchase of property, equipment, and capitalized software: $20,556,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $2,804,123,000.00Net cash from operating activities → Cash sources and uses: $4,711,325,000.00Net cash from financing activities → Cash sources and uses: $9,695,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $4,100,278,000.00Cash sources and uses → Net cash used in investing activities: $3,424,865,000.00Net income: $1,040,851,000.00Net income+$1.04 BDeferred taxes: -$7,731,000.00Deferred income taxes−$7.73 MNet realized gain on sale of financial instruments: -$1,732,000.00Investment sale gain & loss−$1.73 MDepreciation and amortization expense: $13,049,000.00Depreciation & amortization+$13.05 MAmortization of debt issuance costs: $2,163,000.00Debt issuance cost amortization+$2.16 MStock-based compensation expense: $36,623,000.00Stock-based compensation+$36.62 MNet accretion of investments: -$15,285,000.00Investment discount & premium−$15.29 MChange in provision for credit losses: $48,072,000.00Other credit loss provision+$48.07 MReceivables from CMS: -$44,721,000.00Receivables from CMS−$44.72 MAccounts receivable: -$65,448,000.00Accounts receivable−$65.45 MReinsurance recoverable: -$96,794,000.00Reinsurance recoverables−$96.79 MOther assets: -$26,660,000.00Other operating assets−$26.66 MBenefits payable: $443,050,000.00Claims reserves+$443.05 MPayables to CMS: $3,365,194,000.00Payables to CMS+$3.37 BAccounts payable and other liabilities: $20,408,000.00Payables & accrued liabilities+$20.41 MUnearned premiums: $1,302,000.00Unearned premiums+$1.30 MReinsurance payable: -$1,016,000.00Reinsurance payables−$1.02 MNet cash from operating activities: $4,711,325,000.00Operating cash+$4.71 BOperating adjustments reconciliation: $3,929,861,000.00Proceeds from exercise of stock options and stock purchase agreement: $29,904,000.00Stock option exercises+$29.90 MTax payments related to net settlement of share-based awards: -$11,920,000.00Stock-award tax withholding−$11.92 MPayments of debt issuance costs: -$4,919,000.00Debt issuance costs−$4.92 MEarn-out Liability Payout: -$3,370,000.00Contingent consideration paid−$3.37 MNet cash from financing activities: $9,695,000.00Financing cash+$9.70 Mfinancing reconciliation: $29,904,000.00Purchase of investments: -$4,942,801,000.00AFS securities purchases−$4.94 BSale of investments: $983,943,000.00AFS securities sales+$983.94 MMaturity and paydowns of investments: $553,943,000.00AFS securities maturities+$553.94 MPurchase of property, equipment, and capitalized software: -$20,556,000.00Capital expenditures−$20.56 MChange in restricted deposits: $606,000.00Change in restricted deposits+$606.00 KNet cash used in investing activities: -$3,424,865,000.00. Cash required to fund net payments.Investing cash−$3.42 Binvesting reconciliation: $4,963,357,000.00Cash sources and uses: $7,525,143,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $2,804,123,000.00Beginning cash$2.80 BEnding cash: Cash, cash equivalents, and restricted cash: $4,100,278,000.00Ending cash$4.10 BCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsFree cash flow$4.69 BOperating cash − cash spent on productive assetsCash flow / Net income4.53×Operating cash flow ÷ net incomeNet cash change+$1.30 BEnding cash − beginning cash
Chart details

Oscar Health, Inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
2,804,123,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
4,711,325,000 US dollars. Net cash provided.
Net income
1,040,851,000 US dollars
Deferred taxes
negative 7,731,000 US dollars
Net realized gain on sale of financial instruments
negative 1,732,000 US dollars
Depreciation and amortization expense
13,049,000 US dollars
Amortization of debt issuance costs
2,163,000 US dollars
Stock-based compensation expense
36,623,000 US dollars
Net accretion of investments
negative 15,285,000 US dollars
Change in provision for credit losses
48,072,000 US dollars
Receivables from CMS
negative 44,721,000 US dollars
Accounts receivable
negative 65,448,000 US dollars
Reinsurance recoverable
negative 96,794,000 US dollars
Other assets
negative 26,660,000 US dollars
Benefits payable
443,050,000 US dollars
Payables to CMS
3,365,194,000 US dollars
Accounts payable and other liabilities
20,408,000 US dollars
Unearned premiums
1,302,000 US dollars
Reinsurance payable
negative 1,016,000 US dollars
Investing activities
negative 3,424,865,000 US dollars. Net cash used.
Purchase of investments
negative 4,942,801,000 US dollars
Sale of investments
983,943,000 US dollars
Maturity and paydowns of investments
553,943,000 US dollars
Purchase of property, equipment, and capitalized software
negative 20,556,000 US dollars
Change in restricted deposits
606,000 US dollars
Financing activities
9,695,000 US dollars. Net cash provided.
Proceeds from exercise of stock options and stock purchase agreement
29,904,000 US dollars
Tax payments related to net settlement of share-based awards
negative 11,920,000 US dollars
Payments of debt issuance costs
negative 4,919,000 US dollars
Earn-out Liability Payout
negative 3,370,000 US dollars
Operating adjustment reconciliation
3,929,861,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
29,904,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
4,963,357,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
4,100,278,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
7,525,143,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
1,296,155,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
4.53×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
4,711,325,000 US dollars. Operating cash flow used in the free cash flow calculation.
cash spent on productive assets
20,556,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
4,690,769,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $3.67B after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash spent on productive assets equals free cash flow: 4,711,325,000 US dollars minus 20,556,000 US dollars equals 4,690,769,000 US dollars.
Oscar Health, Inc. (OSCR) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!